Many biotechs on the ASX talk alot... we're gunna do this and we're gunna do that. Biota stands out from the crowd, they actually deliver the goods. Be it a cure for the flu or just the common cold, Biota has an excellent pipeline in multi-billion dollar markets. There is no reason they won't be able to catch CSL's market cap in future and even overtake it. Won't happen this year though.